structure p-glycoprotein reveals molecular basis poly-specific drug binding
p-glycoprotein p-gp detoxifies cells exporting hundreds chemically unrelated toxins implicated multidrug resistance mdr treatment cancers substrate promiscuity hallmark p-gp activity thus structural description poly-specific drug-binding important rational design anticancer drugs mdr inhibitors x-ray structure apo p-gp angstroms reveals internal cavity similar angstroms cubed angstrom separation two nucleotide-binding domains two additional p-gp structures cyclic peptide inhibitors demonstrate distinct drug-binding sites internal cavity capable stereoselectivity based hydrophobic aromatic interactions apo drug-bound p-gp structures portals open cytoplasm inner leaflet lipid bilayer drug entry inward-facing conformation represents initial stage transport cycle competent drug binding
